메뉴 건너뛰기
Chinese Journal of Neurology
Volumn 40, Issue 8, 2007, Pages 544-548
Serum excitatory amino acids concentrations in patients with amnestic mild cognitive impairment or Alzheimer's disease
Author keywords

Alzheimer disease; Congition disorders; Excitatory amino acids
Indexed keywords

EID: 84860909628     PISSN: 10067876     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (1)
References (29)
  • 1
    • 0042023711 scopus 로고    scopus 로고
    • Alzheimer disease in the US population: Prevalence estimates using the 2000 census
    • Hebert LE, Scherr PA, Bienias JL, et al. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol, 2003, 60: 1119-1122.
    • (2003) Arch Neurol , vol.60 , pp. 1119-1122
    • Hebert, L.E.1    Scherr, P.A.2    Bienias, J.L.3
  • 2
    • 84860893596 scopus 로고    scopus 로고
    • Chinese source
    • 2002: 307-319.
    • (2002) , pp. 307-319
  • 3
    • 27544474690 scopus 로고    scopus 로고
    • Mild cognitive impairment: Where are we?
    • Petersen RC. Mild cognitive impairment: where are we? Alz Dis Assoc Dis, 2005, 19: 166-169.
    • (2005) Alz Dis Assoc Dis , vol.19 , pp. 166-169
    • Petersen, R.C.1
  • 4
    • 84860891583 scopus 로고    scopus 로고
    • Chinese source
    • 2002, 35: 324-326.
    • (2002) , vol.35 , pp. 324-326
  • 5
    • 84860908550 scopus 로고    scopus 로고
    • Chinese source
    • 2002, 35: 369-371.
    • (2002) , vol.35 , pp. 369-371
  • 6
    • 0032988610 scopus 로고    scopus 로고
    • Mild cognitive impairment: Clinical characterization and outcome
    • Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol, 1999, 56: 303-308.
    • (1999) Arch Neurol , vol.56 , pp. 303-308
    • Petersen, R.C.1    Smith, G.E.2    Waring, S.C.3
  • 7
    • 3042693940 scopus 로고    scopus 로고
    • Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease
    • Matthew RH, Heather LS, Peter RD. Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease. Neurochem Int, 2004, 45: 583-595.
    • (2004) Neurochem Int , vol.45 , pp. 583-595
    • Matthew, R.H.1    Heather, L.S.2    Peter, R.D.3
  • 8
    • 0028762647 scopus 로고
    • Excitatory amino acids as a final common pathway for neurologic disorders
    • Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. New Eng J Med, 1994, 330: 613-622.
    • (1994) New Eng J Med , vol.330 , pp. 613-622
    • Lipton, S.A.1    Rosenberg, P.A.2
  • 9
    • 84860906831 scopus 로고
    • Chinese source
    • 1995, 2: 212-215.
    • (1995) , vol.2 , pp. 212-215
  • 10
    • 19144372322 scopus 로고    scopus 로고
    • Effects of memantine on behavioural symptoms in Alzheimer's disease patients: An analysis of the Neuropsychiatric Inventory (NPI) data of two randomised, controlled studies
    • Gauthier S, Wirth Y, Mobius HJ. Effects of memantine on behavioural symptoms in Alzheimer's disease patients: an analysis of the Neuropsychiatric Inventory (NPI) data of two randomised, controlled studies. Int J Geriatr Psych, 2005, 20: 459-464.
    • (2005) Int J Geriatr Psych , vol.20 , pp. 459-464
    • Gauthier, S.1    Wirth, Y.2    Mobius, H.J.3
  • 11
    • 0038376612 scopus 로고    scopus 로고
    • Memantine for the treatment of dementia
    • Wilcock GK. Memantine for the treatment of dementia. Lancet Neurol, 2003, 2: 503-505.
    • (2003) Lancet Neurol , vol.2 , pp. 503-505
    • Wilcock, G.K.1
  • 12
    • 84860891357 scopus 로고    scopus 로고
    • Chinese source
    • 2005, 26: 541-545.
    • (2005) , vol.26 , pp. 541-545
  • 13
    • 33745661717 scopus 로고    scopus 로고
    • Efficacy and safety of memantine in moderate-to-severe Alzheimer disease: The evidence to date
    • Bullock R. Efficacy and safety of memantine in moderate-to-severe Alzheimer disease: the evidence to date. Alz Dis Assoc Dis, 2006, 20: 23-29.
    • (2006) Alz Dis Assoc Dis , vol.20 , pp. 23-29
    • Bullock, R.1
  • 14
    • 4344685475 scopus 로고    scopus 로고
    • Plasma amino acid concentrations in patients with amnestic mild cognitive impairment or Alzheimer disease
    • Ravaglia G, Forti P, Maioli F, et al. Plasma amino acid concentrations in patients with amnestic mild cognitive impairment or Alzheimer disease. Am J Clin Nutr, 2004, 80: 483-488.
    • (2004) Am J Clin Nutr , vol.80 , pp. 483-488
    • Ravaglia, G.1    Forti, P.2    Maioli, F.3
  • 15
    • 0031800521 scopus 로고    scopus 로고
    • Abnormal amino acid metabolism in patients with early stage Alzheimer dementia
    • Fekkes D, van der Cammen TJ, van Loon CP, et al. Abnormal amino acid metabolism in patients with early stage Alzheimer dementia. J Neural Transm, 1998, 105: 287-294.
    • (1998) J Neural Transm , vol.105 , pp. 287-294
    • Fekkes, D.1    van der Cammen, T.J.2    van Loon, C.P.3
  • 16
    • 0029005597 scopus 로고
    • Free D-serine in postmortem brains and spinal cords of individuals with and without neuropsychiatric diseases
    • Kumashiro S, Hashimoto A, Nishikawa T. Free D-serine in postmortem brains and spinal cords of individuals with and without neuropsychiatric diseases. Brain Res, 1995, 681: 117-125.
    • (1995) Brain Res , vol.681 , pp. 117-125
    • Kumashiro, S.1    Hashimoto, A.2    Nishikawa, T.3
  • 17
    • 84860893595 scopus 로고    scopus 로고
    • Chinese source
    • 2004, 20: 65-71.
    • (2004) , vol.20 , pp. 65-71
  • 18
    • 0346025493 scopus 로고    scopus 로고
    • Functional neurochemistry of Alzheimer's disease
    • Gsell W, Jungkunz G, Riederer P. Functional neurochemistry of Alzheimer's disease. Curr Pharm Design, 2004, 10: 265-293.
    • (2004) Curr Pharm Design , vol.10 , pp. 265-293
    • Gsell, W.1    Jungkunz, G.2    Riederer, P.3
  • 19
    • 0030782939 scopus 로고    scopus 로고
    • Excitotoxic neurodegenation in Alzheimer's disease: New hypothesis and new therapeutic strategies
    • Olney JW, Wozniak DF, Farber NB. Excitotoxic neurodegenation in Alzheimer's disease: new hypothesis and new therapeutic strategies. Arch Neurol, 1997, 54: 1234-1240.
    • (1997) Arch Neurol , vol.54 , pp. 1234-1240
    • Olney, J.W.1    Wozniak, D.F.2    Farber, N.B.3
  • 20
    • 0029102993 scopus 로고
    • Neurodegeneration mediated by glutamate and β-amyloid peptide: A comparison and possible interaction
    • Gray C W, Patel AJ. Neurodegeneration mediated by glutamate and β-amyloid peptide: a comparison and possible interaction. Brain Res, 1995, 691: 169-179.
    • (1995) Brain Res , vol.691 , pp. 169-179
    • Gray, C.W.1    Patel, A.J.2
  • 21
    • 3242786300 scopus 로고    scopus 로고
    • Enhancement of NMDA responses by β-amyloid peptides in the hippocampus in vivo
    • Molnar Z, Soos K, Lengyel I, et al. Enhancement of NMDA responses by β-amyloid peptides in the hippocampus in vivo. J Neurochem, 2004, 15: 1649-1652.
    • (2004) J Neurochem , vol.15 , pp. 1649-1652
    • Molnar, Z.1    Soos, K.2    Lengyel, I.3
  • 22
    • 0017648362 scopus 로고
    • Studies of the interrelationship between cerebrospinal fluid and plasma amino acid concentrations in normal individuals
    • McGale EH, Pye IF, Stonier C, et al. Studies of the interrelationship between cerebrospinal fluid and plasma amino acid concentrations in normal individuals. J Neurochem, 1977, 29: 291-297.
    • (1977) J Neurochem , vol.29 , pp. 291-297
    • McGale, E.H.1    Pye, I.F.2    Stonier, C.3
  • 23
    • 7144257853 scopus 로고    scopus 로고
    • Neurotransmitter amino acid in cerebrospinal fluid of patients with Alzheimer's disease
    • Jimenez-Jimenez FJ, Molina JA, Gomez P, et al. Neurotransmitter amino acid in cerebrospinal fluid of patients with Alzheimer's disease. J Neural Transm, 1998, 105: 269-277.
    • (1998) J Neural Transm , vol.105 , pp. 269-277
    • Jimenez-Jimenez, F.J.1    Molina, J.A.2    Gomez, P.3
  • 24
    • 0027363465 scopus 로고
    • Amino acid concentrantions in cerebrospinal fluid and serum in Alzheimer's disease and vascular dementia
    • Martinez M, Frank A, Diez-Tejedor E, et al. Amino acid concentrantions in cerebrospinal fluid and serum in Alzheimer's disease and vascular dementia. J Neural Transm, 1993, 6: 1-9.
    • (1993) J Neural Transm , vol.6 , pp. 1-9
    • Martinez, M.1    Frank, A.2    Diez-Tejedor, E.3
  • 25
    • 0043172479 scopus 로고    scopus 로고
    • Glutamatergic system and Alzheimer's disease
    • Butterfield DA, Pocernich CB. Glutamatergic system and Alzheimer's disease. CNS Drugs, 2003, 17: 641-652.
    • (2003) CNS Drugs , vol.17 , pp. 641-652
    • Butterfield, D.A.1    Pocernich, C.B.2
  • 26
    • 0026584080 scopus 로고
    • Glutamte and other CSF amino acid in Alzheimer's disease
    • Pomara N, Singh R, Deptula D, et al. Glutamte and other CSF amino acid in Alzheimer's disease. Am J Psychiat, 1992, 149: 251-254.
    • (1992) Am J Psychiat , vol.149 , pp. 251-254
    • Pomara, N.1    Singh, R.2    Deptula, D.3
  • 27
    • 0030785768 scopus 로고    scopus 로고
    • Decreased expression of NMDA receptor 1 mRNA in select regions of Alzheimer brain
    • Ulas J, Cotman CW. Decreased expression of NMDA receptor 1 mRNA in select regions of Alzheimer brain. Neuroscience, 1997, 79: 973-982.
    • (1997) Neuroscience , vol.79 , pp. 973-982
    • Ulas, J.1    Cotman, C.W.2
  • 28
    • 1642329138 scopus 로고    scopus 로고
    • Amnestic MCI or prodromal Alzheimer's disease?
    • Dubosis B, Albert ML. Amnestic MCI or prodromal Alzheimer's disease? Lancet Neurol, 2004, 3: 246-248.
    • (2004) Lancet Neurol , vol.3 , pp. 246-248
    • Dubosis, B.1    Albert, M.L.2
  • 29
    • 0035195760 scopus 로고    scopus 로고
    • Current concepts in mild cognitive impairment
    • Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol, 2001, 58: 1985-1992.
    • (2001) Arch Neurol , vol.58 , pp. 1985-1992
    • Petersen, R.C.1    Doody, R.2    Kurz, A.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.